Description
YUSIMRY (adalimumab-aqvh) is a prescription biologic drug that blocks tumor necrosis factor, a protein involved in inflammation. It's a monoclonal antibody used to treat autoimmune conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel diseases. Administered as a subcutaneous injection, each dose contains 40 mg of the active ingredient. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Adalimumab-aqvh | HTML | Access the FDA dataset for Adalimumab-aqvh — ANDA 761216 submitted by Mylan Institutional LLC | Open resource |